07/11/19 -"We have made some adjustments to take into account the huge impairment and added some first costs (€120m for 2019-21) in the implementation of the €300-350m cost reduction plan to our P&L. "
Pages
57
Language
English
Published on
07/11/19
You may also be interested by these reports :
20/02/26
Umicore reported broadly flat YoY sales, in line with consensus. We expect a flattish sales growth into FY26 ex. metals exposure, as we anticipate ...
19/02/26
Of note: Cementir has been tracked by AlphaValue as part of a sponsored research contract since 2019. Cement is nobody’s instinctive climate ...
12/02/26
DSM’s full-year results aligned closely with expectations, achieving 3.0% organic revenue growth, just below the 3.1% consensus forecast (a 10bps ...
12/02/26
1H25/26 remained below expectations – Reduced FY25/26E sales guidance